Bristol-Myers Squibb Company
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $10.61B | $5.25B | $2.17B |
| Depreciation & Amortization | — | — | — |
| Depreciation | $469.0M | $562.0M | $542.0M |
| Amortization | $-170.0M | — | — |
| Stock-Based Compensation | $183.0M | $181.0M | $133.0M |
| Net Cash from Operating Activities | $4.07B | $3.71B | $3.15B |
| Investing Activities | |||
| Capital Expenditures | $730.0M | $941.0M | $843.0M |
| Business Acquisitions | $2.23B | $191.0M | $432.0M |
| Net Cash from Investing Activities | $-4.38B | $5.08B | $-202.0M |
| Financing Activities | |||
| Dividends Paid | $2.48B | $2.46B | $2.21B |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $-17.0M | $-2.58B | $-3.21B |
| Net Change in Cash | $-293.0M | $6.18B | $-217.0M |
| Free Cash Flow | $3.34B | $2.77B | $2.31B |